The effects of extrafine beclomethasone/formoterol on hyperinflation and airway geometry in COPD patients

被引：0
作者：
Vinchurkar, Samir [1 ]
Vos, Wim [1 ]
Holsbeke, Cedric [1 ]
De Backer, Jan [1 ]
Poli, Gianluigi [2 ]
De Backer, Wilfried [3 ]
机构：
[1] FluidDA nv, Res & Dev, Antwerp, Belgium
[2] CHIESI, Res & Dev, Parma, Italy
[3] Univ Hosp Antwerp, Resp Med, Antwerp, Belgium
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Airway management; COPD; -; management; mechanism;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3761
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations
    Wedzicha, J. A.
    Singh, D.
    Vestbo, J.
    Paggiaro, P. L.
    Jones, P. W.
    Bonnet-Gonod, F.
    Cohuet, G.
    Corradi, M.
    Vezzoli, S.
    Petruzzelli, S.
    Agusti, A.
    RESPIRATORY MEDICINE, 2014, 108 (08) : 1153 - 1162
  • [2] FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbations
    Agusti, Alvar
    Corradi, Massimo
    Cohuet, Geraldine
    Vezzoli, Stefano
    Singh, Dave
    Vestbo, Jorgen
    Paggiaro, Pierluigi
    Jones, Paul
    Petruzzelli, Stefano
    Wedzicha, Jawidga
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [3] Cardiovascular safety of extrafine beclomethasone/formoterol (BDP/FF) delivered via a novel dry powder inhaler (NEXThalere®) in COPD patients
    Singh, Dave
    Ciurlia, Giorgia
    Piccinno, Annalisa
    Compagnoni, Anna
    Bocchi, Maria
    Scuri, Mario
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [4] Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD
    van Noord, JA
    Aumann, JL
    Janssens, E
    Verhaert, J
    Smeets, JJ
    Mueller, A
    Cornelissen, PJG
    CHEST, 2006, 129 (03) : 509 - 517
  • [5] Beclomethasone/Formoterol in Extra-Fine Formulation Improves Small Airway Dysfunction in COPD Patients
    Pisi, Roberta
    Aiello, Marina
    Piraino, Alessio
    Paleari, Davide
    Frizzelli, Annalisa
    Bertorelli, Giuseppina
    Chetta, Alfredo
    PULMONARY THERAPY, 2021, 7 (01) : 133 - 143
  • [6] Beclomethasone/Formoterol in Extra-Fine Formulation Improves Small Airway Dysfunction in COPD Patients
    Roberta Pisi
    Marina Aiello
    Alessio Piraino
    Davide Paleari
    Annalisa Frizzelli
    Giuseppina Bertorelli
    Alfredo Chetta
    Pulmonary Therapy, 2021, 7 : 133 - 143
  • [7] Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD
    Montuschi, Paolo
    Santini, Giuseppe
    Mores, Nadia
    Vignoli, Alessia
    Macagno, Francesco
    Shoreh, Rugia
    Tenori, Leonardo
    Zini, Gina
    Fuso, Leonello
    Mondino, Chiara
    Di Natale, Corrado
    D'Amico, Arnaldo
    Luchinat, Claudio
    Barnes, Peter J.
    Higenbottam, Tim
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [8] Novel Functional Imaging of Changes in Small Airways of Patients Treated with Extrafine Beclomethasone/Formoterol
    Vos, Wim
    De Backer, Jan
    Poli, Gianluigi
    De Volder, Annick
    Ghys, Liesbet
    Van Holsbeke, Cedric
    Vinchurkar, Samir
    De Backer, Lieve
    De Backer, Wilfried
    RESPIRATION, 2013, 86 (05) : 393 - 401
  • [9] In vitro validation of the use of a spacer with an extrafine beclomethasone/formoterol formulation
    Furon, Emeline
    Poree, Thierry
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [10] Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
    Singh, Dave
    Corradi, Massimo
    Spinola, Monica
    Papi, Alberto
    Usmani, Omar S.
    Scuri, Mario
    Petruzzelli, Stefano
    Vestbo, Jorgen
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 2917 - 2928
12345